U.S. SenateSTOCK Act Disclosure
Photo of John Boozman

Senator John Boozman discloses nine joint stock purchases made in April 2025, including shares of Microsoft, UnitedHealth, and Meta, with a total value of up to $135,000.

Filer
John Boozman (AR)
Transactions
9 across 5 companies
Direction
9 bought · 0 sold
Notification date
08/20/2026

All 9 transactions in this filing

CompanyTickerTypeAmountDate
UNITEDHEALTH GROUP INCUNHPurchase$1,001 - $15,00004/16/2025
Oracle CorpPurchase$1,001 - $15,00004/16/2025
MICROSOFT CORPMSFTPurchase$1,001 - $15,00004/22/2025
MICROSOFT CORPMSFTPurchase$1,001 - $15,00004/16/2025
Meta Platforms, Inc.METAPurchase$1,001 - $15,00004/15/2025
iShares iBoxx $ High Yield Corporate Bond ETFPurchase$1,001 - $15,00004/09/2025
COLGATE PALMOLIVE LTD.Purchase$1,001 - $15,00004/08/2025
Cboe Global Markets, Inc.CBOEPurchase$1,001 - $15,00004/08/2025
Broadcom Inc.AVGOPurchase$1,001 - $15,00004/08/2025

Senator John Boozman disclosed nine transactions in an amended Periodic Transaction Report filed on August 20, 2026. All transactions were purchases made in a joint account during April 2025. The total value of these purchases is estimated to be between $9,009 and $135,000.

The disclosed purchases were all in individual stocks or an ETF, with each transaction valued between $1,001 and $15,000. The assets acquired include shares in major technology and healthcare companies.

Specifically, the report details two separate purchases of Microsoft Corp (MSFT) stock. Other technology companies purchased include Oracle Corp (ORCL), Meta Platforms Inc (META), and Broadcom Inc. (AVGO). The filing also shows purchases of Unitedhealth Group Inc (UNH), Cboe Global Markets, Inc. (CBOE), Colgate Palmolive Ltd. (COLPAL), and the iShares iBoxx $ High Yield Corporate Bond ETF (HYG).

Important Disclaimer

Amounts are disclosed by law as broad ranges, not exact figures - this reflects the range as filed, not a precise dollar amount. This content is summarized from a public government disclosure filing and may contain errors.

The Filing Fool is not a registered investment adviser. Nothing here is a recommendation or solicitation to buy, sell, or hold any security, nor any claim about a filer's intent or knowledge.